Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WEED Inc BUDZ

WEED, Inc. is engaged in the business involving the purchase of land and building commercial grade cultivation centers to consult, assist, manage and lease to licensed dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.


OTCQB:BUDZ - Post by User

Comment by SusanBollandon Oct 18, 2021 1:48pm
78 Views
Post# 34018956

RE:LACQ - Enscysce Sciences

RE:LACQ - Enscysce Sciences
Snoinam wrote: Enscysce Sciences - Solving the opioid crisis. LACQ and LACQW are the tickers. Biopharma IPO through a SPAC merger. Big opportunity to buy the warrants which are undervalued to the commons. https://www.google.com/url?sa=t&source=web&rct=j&url=https://ensysce.com/&ved=2ahUKEwiN9ZvstNjuAhULpp4KHfQQDckQFjACegQICxAC&usg=AOvVaw3FSO4vp18YJTJ4fFf3Mj7n

thanks for the post
<< Previous
Bullboard Posts
Next >>